Press-release for stocks for tcrr

Prices are updated after-hours

TCR² Therapeutics Announces Commercial Cell Therapy Leader Shawn Tomasello Joins its Board of Directors
Published: 2021-02-04 (Crawled : 13:03) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M

| -94.38% | O: 0.34% H: 6.89% C: 6.02%
therapy commercialization

TCR² Therapeutics Announces 2021 Strategic Priorities and Milestones
Published: 2021-01-08 (Crawled : 13:03) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M

| -95.06% | O: -0.23% H: 8.13% C: 8.03%
therapeutics milestone

TCR² Therapeutics to Present at J.P. Morgan Healthcare Conference
Published: 2020-12-21 (Crawled : 13:03) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M

| -94.97% | O: -3.29% H: 2.32% C: 1.86%
j.p. morgan healthcare conference conference presentation therapeutics

67%

33%

JOE 4 | $54.88 1.22% 0.22% 210K

Save your searches and get alerts when important news are released.